Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oppizzi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical Endocrinology|October 1, 1977
Evidence for a dopaminergic activity of methysergide in humansG Oppizzi, G Verde, L De Stefano, et al.
Journal of Endocrinological Investigation|May 9, 2000
From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's diseaseM Barausse, R Attanasio, D Dallabonzana, et al.
Journal of Endocrinological Investigation|November 19, 1997
Effects of tamoxifen on GH and IGF-I levels in acromegalyR Cozzi, R Attanasio, G Oppizzi, et al.
Acta Endocrinologica|May 1, 1993
CV 205-502 in acromegalyP G Chiodini, R Attanasio, R Cozzi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1976
Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patientsP G Chiodini, A Liuzzi, E E Muller, et al.
Metabolism: Clinical and Experimental|August 1, 1996
Nonfunctioning adenomas of the pituitaryA Liuzzi, V Tassi, M T Pirro, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptineP G Chiodini, R Cozzi, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative tergurideD Dallabonzana, A Liuzzi, G Oppizzi, et al.
European Journal of Endocrinology|January 1, 1995
Persistence of somatostatinergic tone in acromegalyR Attanasio, R Cozzi, G Oppizzi, et al.
European Journal of Endocrinology|December 16, 1998
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?R Cozzi, R Attanasio, M Barausse, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Endocrinology|October 1, 1977
Evidence for a dopaminergic activity of methysergide in humansG Oppizzi, G Verde, L De Stefano, et al.
Journal of Endocrinological Investigation|May 9, 2000
From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's diseaseM Barausse, R Attanasio, D Dallabonzana, et al.
Journal of Endocrinological Investigation|November 19, 1997
Effects of tamoxifen on GH and IGF-I levels in acromegalyR Cozzi, R Attanasio, G Oppizzi, et al.
Acta Endocrinologica|May 1, 1993
CV 205-502 in acromegalyP G Chiodini, R Attanasio, R Cozzi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1976
Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patientsP G Chiodini, A Liuzzi, E E Muller, et al.
Metabolism: Clinical and Experimental|August 1, 1996
Nonfunctioning adenomas of the pituitaryA Liuzzi, V Tassi, M T Pirro, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptineP G Chiodini, R Cozzi, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative tergurideD Dallabonzana, A Liuzzi, G Oppizzi, et al.
European Journal of Endocrinology|January 1, 1995
Persistence of somatostatinergic tone in acromegalyR Attanasio, R Cozzi, G Oppizzi, et al.
European Journal of Endocrinology|December 16, 1998
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?R Cozzi, R Attanasio, M Barausse, et al.
Pageof 4